Serological Diagnosis of Idiopathic Pulmonary Alveolar Proteinosis
Top Cited Papers
- 1 August 2000
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 162 (2) , 658-662
- https://doi.org/10.1164/ajrccm.162.2.9910032
Abstract
Previously, we reported the specific occurrence of neutralizing autoantibodies against granulocyte–macrophage colony–stimulating factor (GM-CSF) in the bronchoalveolar lavage fluid from 11 Japanese patients with idiopathic pulmonary alveolar proteinosis (I-PAP). The autoantibody was also detected in sera from all 5 I-PAP patients examined. To determine that the existence of the autoantibody is not limited to the Japanese patients, we examined sera from 24 I-PAP patients in five countries and showed that the autoantibody was consistently and specifically present in such patients. Thus, detection of the autoantibody in sera can be used for diagnosis of I-PAP. To establish a simple and convenient method for diagnosis of I-PAP, we developed a novel latex agglutination test using latex beads coupled with recombinant human GM-CSF. GM-CSF binding proteins isolated from the sera using the latex beads were identified as the autoantibodies of IgG1 and IgG2. The titer of the autoantibody determined by this test correlated with that determined by ELISA. Agglutination was positive in 300-fold diluted sera from all 24 I-PAP patients, but negative in sera from four secondary PAP patients, two congenital PAP patients, 40 patients with other lung diseases, and 38 of 40 normal subjects. These results establish that the latex agglutination test is a reliable method for serological diagnosis of I-PAP with high sensitivity (100%) and specificity (98%).Keywords
This publication has 15 references indexed in Scilit:
- Idiopathic Pulmonary Alveolar Proteinosis as an Autoimmune Disease with Neutralizing Antibody against Granulocyte/Macrophage Colony-Stimulating FactorThe Journal of Experimental Medicine, 1999
- Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte‐macrophage colony stimulating factorFEBS Letters, 1999
- Serum and Bronchoalveolar Fluid KL-6 Levels in Patients with Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Degradation of surfactant protein D by alveolar macrophagesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1998
- Diagnosing Pulmonary Alveolar ProteinosisChest, 1997
- Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage.American Journal of Respiratory and Critical Care Medicine, 1996
- Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapyClinical and Experimental Immunology, 1996
- Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietinJournal of Cellular Physiology, 1989
- Degradation of pulmonary surfactant disaturated phosphatidylcholines by alveolar macrophagesJournal of Applied Physiology, 1988
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983